EOLS EVOLUS INC
2026Q1 · CUSIP 30052C107 · Sector: Healthcare & Biotech
Neutral · No signal
Holders
144
Δ holders QoQ
-23
Breadth percentile
Top 93%
Whale holders
70
Δ whales
-8
Inst. holding value
$188M
New positions
27
Closed positions
50
Price momentum (1Q)
+49.7%
Put / Call
3/5
Breadth history (34 quarters)
Past Lit Events & Aftermath 8 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2025Q1 | Top 14% | -28.0% | -29.8% |
| 2022Q3 | Top 15% | +19.7% | +27.6% |
| 2022Q1 | Top 14% | -27.8% | -45.9% |
| 2021Q2 | Top 13% | -35.5% | -21.0% |
| 2019Q2 | Top 14% | — | — |
| 2019Q1 | Top 18% | — | — |
| 2018Q3 | Top 16% | +66.8% | +18.5% |
| 2018Q2 | Top 16% | — | — |
Options Sentiment
Put holders
3
QoQ: +1
Call holders
5
QoQ: +2
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-0.66
EPS YoY
—
Revenue (TTM)
$0.3B
Revenue YoY
+9.6%
Net margin
-14.4%
ROE
—
Debt ratio
113.0%
FCF (TTM)
-$40M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
As of 2026-03-31 · SEC filings (XBRL)
Get the next update
2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.